Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $3.7 million.

  • Utah Medical Products' Total Liabilities fell 3227.21% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 3227.21%. This contributed to the annual value of $5.1 million for FY2024, which is 2846.75% down from last year.
  • As of Q3 2025, Utah Medical Products' Total Liabilities stood at $3.7 million, which was down 3227.21% from $3.3 million recorded in Q2 2025.
  • Utah Medical Products' 5-year Total Liabilities high stood at $10.6 million for Q1 2022, and its period low was $3.3 million during Q2 2025.
  • Moreover, its 5-year median value for Total Liabilities was $8.5 million (2021), whereas its average is $7.7 million.
  • In the last 5 years, Utah Medical Products' Total Liabilities soared by 1418.02% in 2021 and then tumbled by 4533.44% in 2025.
  • Quarter analysis of 5 years shows Utah Medical Products' Total Liabilities stood at $8.5 million in 2021, then grew by 13.2% to $9.6 million in 2022, then decreased by 25.73% to $7.1 million in 2023, then dropped by 28.47% to $5.1 million in 2024, then fell by 27.16% to $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q3 2025, $3.3 million for Q2 2025, and $5.5 million during Q1 2025.